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Effects of brodifacoum and diphacinone
exposure on four species of reptiles: tissue
residue levels and survivorship
Richard E Mauldin, Gary W Witmer, Susan A Shriner, Rachael S Moulton
and Katherine E Horak*
Abstract
BACKGROUND: Anticoagulant rodenticides are usedworldwide to control pest rodent species. However, the risks posed to non-
target reptiles have not been well characterized. In this study, 46 giant ameivas (Ameiva ameiva), 39 boa constrictors (Boa con-
strictor), 33 wood turtles (Rhinoclemmys pulcherrima), and 47 green iguanas (Iguana iguana) were orally dosed with one of two
levels of either diphacinone or brodifacoumanticoagulant in propylene glycol solutions. Dosageswere derived using daily food
intake (DFI) equations, converting DFI to an equivalent anticoagulant bait amount and gavaging the solution volume needed to
deliver the quantity of anticoagulant in that amount of bait. Animals were dosed on days 0 and 7 and monitored for a further
7 days for signs of anticoagulant intoxication and differences in behaviors and postures. At necropsy on day 14, animals were
examined for thoracic and abdominal bleeding, and both tissue and organ samples were taken for histology. Liver and whole-
body anticoagulant residues were assessed.
RESULTS: No turtles or boas died due to anticoagulant exposure. However, anticoagulant intoxication was suspected in one
iguana dosed with brodifacoum. A few treated ameivas died but exhibited no hemorrhaging. Liver residue levels were higher
thanwhole-body remainder residue levels for all species. Unlike the other species, turtles had higher diphacinone residue levels
than brodifacoum.
CONCLUSION: Turtles and boas exhibited a relative insensitivity to diphacinone and brodifacoum, while the lizards appeared to
be somewhat more sensitive to these compounds. This study provides data for future assessments of the risks to these species
associated with anticoagulant use.
Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
Keywords: brodifacoum; diphacinone; iguana; giant ameiva; boa constrictor; wood turtle; residue; reptile; anticoagulant; behavior
1 INTRODUCTION
The introduction of rodents and other non-native mammals to
island ecosystems poses a serious risk to native species.1,2 These
native species have often evolved without pressure from predators
and therefore invasive rats frequently cause a precipitous decline in
population size, leading to these species being listed as threatened
and endangered or extinct.3,4 Moreover, rodents cause serious
damage to agricultural crops and pose a threat to human health
through the spread of disease.5 Because of these negative impacts
there has been a concerted effort to control rodent populations
and eradicate introduced rodents from islands.1,6,7 Anticoagulant
rodenticides are the mainstay for these rodent control operations.
Although numerous studies and surveillance programs have
been done to assess the risks and exposure of non-target animals
to anticoagulant rodenticides, little is known about risks posed to
non-target reptiles.8–12 Reports of reptile mortality associated
with routine brodifacoum baiting operations are uncommon. In
two separate observations, single dead moko skinks (Oligosoma
moco) were found near baiting stations at two locations in
New Zealand.13 One skink contained a brodifacoum residue
(probably whole body) of 0.82 μg g−1, while analysis of stomach
contents in another skink showed a concentration of 19 μg g−1
of pindone. Necropsy of the second skink found blood clots ven-
tral and caudal to the heart.13 A single Northland green gecko
(Naultinus grayii) was found dead after pindone baiting opera-
tions near Boundary Stream, New Zealand and contained
0.52 μg g−1 pindone. This level of pindone was similar to the con-
centration found in the baits.13 During a 2-month rabbit eradica-
tion program on Round Island, Mauritius using brodifacoum
pelleted baits (20 μg g−1 brodifacoum a.i.), Merton14 noted that
of the several local species of skinks and geckos, only Telfair's
skinks (Leiolopisma telfairii) routinely consumed bait pellets. After
3 weeks of bait exposure, dead skinks were observed, with
increasing mortality over the next 5 weeks, after which no
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additional dead skinks were found. Over 100 dead Telfair's skinks
(out of an estimated population of 5000) were found, primarily
during the warmest parts of the day and on the warmest days.
Pitt et al.6 collected geckos (Lepidodactylus lugubris and Hemi-
dactylus frenatus) on five separate occasions both pre- and post-
brodifacoum bait application spanning a 2-month period on Pal-
myra Atoll. All pre-treatment brodifacoum residue levels were less
than the method limit of detection, while the post-treatment res-
idues ranged from 0.012 to 067 μg g−1. Bettink15 collected eight
dead King's skink (Egernia kingii) over a 3-month period following
baiting with a brodifacoum (0.05 mg kg−1) bait on Penguin Island,
Western Australia, with hemorrhaging the likely cause of death.
Following flocoumafen baiting in the Chafarinas Islands
(Mediterranean), Sanchez-Barbudo16 found one dead horseshoe
whip snake (Hemorrhois hippocrepis) with a liver flocoumafen con-
centration of 0.54 μg g−1 w.w.
Despite these reports of anticoagulant exposure in reptiles,
Hoare and Hare17 found a lack of information about the potential
risks of anticoagulants to non-target reptiles in a review of brodi-
facoum use. Lohr and Davis18 found a similar shortage of reptile-
specific data when reviewing anticoagulant bait use in Australia.
Continued studies examining non-target risk to reptiles following
anticoagulant treatment were also advocated by Herrera et al.19
following a study monitoring survivorship in two lizard species
(Ameiva desechensis and Anolis desechensis) on Desecheo Island
(Puerto Rico) before, during, and after baiting with brodifacoum.
No mortality was found in either species.
Very few laboratory studies have been done to determine the
lethality or physiological effect of anticoagulants on reptiles. Brooks
and colleagues20 orally dosed brown tree snakes (Boiga irregularis)
with warfarin or diphacinone and determined that the LD50 was
40 mg kg−1 and 40–80 mg kg−1, respectively; however, none of
the animals showed signs of distress and there was no internal
bleeding noted upon necropsy.20 In a separate study of McCann's
skinks (Leiolopisma maccannii), animals consumed brodifacoum
bait but there was no mortality in this short 2-day test.21 Because
of their widespread use and the lack of data on the effect of antico-
agulants on reptile species, additional controlled studies need to be
done on more species within this vertebrate class.
As an initial step, the objective of this study was to determine
potential non-target risks in four reptile species representing various
reptile taxa that might be encountered in anticoagulant-based insu-
lar rodent eradication efforts, especially in the western hemisphere.
Giant ameivas (Ameiva ameiva), boa constrictors (Boa constrictor),
Central American wood turtles (Rhinoclemmys pulcherrima), and
green iguanas (Iguana iguana) were orally dosed with one of two
levels of the anticoagulants diphacinone or brodifacoum. Species
were chosen to represent different reptilian taxa and primary dietary
consumption types (carnivore, herbivore, etc.) and associated diges-
tive adaptations to determine if anticoagulants interacted differ-
ently with dietary type (boas are obligate carnivores, turtles are
omnivores, ameivas are insectivores, and iguanas are primarily her-
bivores). Animals were observed for signs of intoxication, comparing
various behaviors and resting postures pre and post treatment to
assess non-lethal but toxicant-related behavioral effects.
2 MATERIALS AND METHODS
2.1 Animal care and housing
2.1.1 General
All animals were purchased from commercial suppliers. Boas were
obtained from several private breeders while iguanas, ameivas,
and wood turtles were wild-caught. On arrival, all animals were
weighed, sexed, and hydrated by placement in shallow tubs con-
taining water.
Size-appropriate PVC hides (PVC pipe cut lengthwise) were pro-
vided for all animals except large and small boas (see boa con-
strictor section), and water was provided in bowls ad libitum.
Turtle and boa cage floors were initially covered with newspaper,
while lizard cage floors were covered with aspen chips (Sani-
Chips, PJ Murphy; Montville, NJ, USA). For turtles and lizards,
newspaper was also taped over the side of the cage facing the
open room to visually occlude the observers.
All animals were housed in an environmentally controlled room
measuring 3.75 × 14.1 m maintained at ≈28 °C (for turtles and
boas) or ≈26 °C (ameivas, iguanas) and 60–65% relative humidity
with a 12 h light/12 h dark photocycle (lights on at 0700 h Moun-
tain Standard Time (MST), off at 1900 h MST). A data logger
(Edstrom Industries, Waterford, WI, USA) placed in center of the
room continuously monitored temperature, humidity, and photo-
period. Two large box fans kept the room air circulating and both
temperatures and humidity homogeneous. Turtles, iguanas, and
ameivas received additional light and basking heat by incandes-
cent 40 W bulbs mounted to the rear or sides of their cages using
clamp lights with reflectors. For iguanas and ameivas, aquarium
fronts were coveredwith newspaper tominimize animal reactions
to animal care staff and observers.
The study was performed under protocol QA-1434 and
approved by the National Wildlife Research Center Institutional
Animal Care and Use Committee. All methods were carried out
in accordance with the relevant guidelines and regulations.
Turtles. Following receipt, each turtle was placed singly in a
clear, polycarbonate boxmeasuring 20.3 cm (height, H) × 40.6 cm
(width, W) × 55.9 cm (length, L) with a weighted wire top. Individ-
ual cages were then mounted into a rack (Techniplast, West Ches-
ter, PA, USA). Hides were located in the front of the cage.
Water was provided in a small shallow bowl ad lib and food
(a pre-weighed mixture of mixed greens, carrots, peas, straw-
berries, and celery) was provided at 0930 h in a shallow Petri dish
which was removed and reweighed prior to lights off at ≈1800 h.
Turtles were kept in quarantine for 54 days and weighed monthly
to ensure acclimation and stable/increasing body weight prior to
treatment.
Boa constrictors. On arrival, boas ranged in weight from 0.34 to
5.0 kg. Each boa was sprayed with a miticidal Ivermectin solution
and housed separately, with the largest boas (>2 kg) being
housed in large, modified rabbit cages (45.7 cm
H × 76.2 cm W × 76.2 cm L). Each cage was then placed in a rack
(Allentown Caging Equipment, Allentown, PA, USA). Grated cage
doors were covered with cardboard to prevent escape or injury.
Undercage heating (≈34.5 °C) was provided by a 15.2-cm wide
band of mylar substrate heat tape taped across the underside of
the rear of the cage (Ultratherm, Scotland, UK).
Medium-sized boas (0.7–1.99 kg) were housed individually in
cages (23.5 cm H × 43.2 cm W × 64.8 cm L) which were then
loaded in a rack (Freedom Breeder, Turlock, CA, USA). Undercage
heating was provided as previously described for large boas. For
medium boas, large (3 L, 8.9 cm H × 27.3 cm diameter) and
medium (1 L, 2.9 cm H × 22.2 cm diameter) plastic dog water
bowls with a hole cut in the side provided both water and a hiding
space under of the bowl. Newspaper was initially used as bedding.
Boas were fed weekly with size-appropriate frozen/thawed mice
or rats, and were held in observation/quarantine for 14 days and
weighed once over that period.
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Iguanas. Newly arrived iguanas ranged in weight from 0.053 to
0.59 kg. The ten largest iguanas (0.385–0.59 kg) were kept in
15 gal (56.8 L) aquaria (30.5 cm H × 30.5 cm W × 61 cm L). Smal-
ler iguanas (0.053–0.33 kg) were kept in 10 gal (37.9 L) aquaria
(30.5 cm H × 25.4 cm W × 50.8 cm L). All aquaria had wire mesh
tops weighted to prevent escape. Aspen chips (Sani-Chips, PJ
Murphy, Montville, NJ, USA) were initially used as bedding.
Iguanas were fed a pre-weighed mixture of mixed greens,
squash, sweet potatoes, peas, melons, mangos, papaya, bananas,
apples, cooked rice/pasta, and whole wheat bread. Feed was
placed in a Petri dish at the front of the aquarium and handled as
described for turtles. Iguanas were held in quarantine for 21 days.
Ameivas. Ameivas initially ranged in weight from 0.013 to
0.159 kg. As described in the iguana section, the largest ten ameivas
(0.095–0.159 kg) were housed in 15 gal aquaria, while the remaining
ameivas (0.013–0.089 kg) were housed in 10 gal aquaria. Ameivas
were fed an insectivorous diet of crickets, waxworm larvae, and sev-
eral roach species, and were kept in quarantine for 13 days.
2.1.2 Behavior/posture observations
We selected a set of behaviors commonly associated with either
normal conditions or distress in reptiles a priori, and postures
which might also be used to distinguish normal from abnormal
behavior were noted during the quarantine phase of the study.
Behavioral observations were made throughout the quarantine
and treatment phases of the study as unobtrusively as possible.
For turtles and both lizard species, the behaviors watched for
were (i) sleeping, (ii) inactive (awake), (iii) hyperactive,
(iv) climbing, (v) walking, (vi) tremors, (vii) comatose, and
(viii) eating. Sleeping animals generally opened their eyes while
being observed; animals that did not do so usually responded to
a light tapping of the cage. Animals that did not respond at this
point but breathing were gently prodded and if unresponsive
were noted as comatose. Hyperactivity was defined as continu-
ous, highly excited movement as opposed to normal locomotion.
Boas were watched for the same behaviors with writhing
substituted for walking as an indication of discomfort, and sleep-
ing (difficult to determine) omitted. In turtles, the activity referred
to as ‘pumping’ (limbs rapidly in and out) was included as a pos-
ture, but could also have been included as a behavior. The pos-
tures noted are summarized in Table 1. During the quarantine
phase, animals were observed twice daily at 0930 h and 1500 h.
2.2 Dosing
For all animals, bedding was removed prior to the beginning of
the study and replaced with light-brown indented kraft paper
(2400 roll (61 cm); Uline, Dallas, TX, USA) visualization of possible
emesis/regurgitation or bleeding following treatment. Approxi-
mately 24 h prior to treatment, all animals were fasted, weighed,
and weight-ranked. Using the online randomization program
Research Randomizer (http://www.randomizer.org/about.htm),
all animals were randomly assigned to one of the five treatment
groups: control, diphacinone 1× (diphacinone low), diphacinone
10× (diphacinone high), brodifacoum 1× (brodifacoum low), brodi-
facoum 10× (brodifacoum high). During the dosing session, each
animal was re-weighed in order to calculate the mass of food each
animal would hypothetically consume and the equivalent antico-
agulant dosage. Experimental numbers by species and sex are
shown in Table 2.
As a first attempt at estimating toxicant intake for species with
such significant dietary and size differences, dosages were calcu-
lated using dry matter ingestion rates (g day−1) for herbivorous
and insectivorous iguanids22 (Table 3). For turtles, boa constric-
tors, and ameivas (represented by the equation for insectivorous
iguanids), the anticoagulant dose was calculated as
FI = 0.013Wt0.773 where FI is the food ingested in grams (dry
weight per day) andWt is the body weight of the animal in grams.
For iguanas, a largely herbivorous iguanid, the equation used was
FI = 0.019Wt0.841. Thus, animals were administered a dose of
diphacinone or brodifacoum equivalent to the quantity of the
compound they would be exposed to if only brodifacoum or diphaci-
none baits (0.0025% and 0.005% active ingredient, respectively) was
consumed for 1 day. This quantity represents the 1×dose of either tox-
icant (referred to as low dose), and is a dosewhich likely overestimates
what the animalswould consume (if they consumedbait directly at all).
To investigate a ‘worst case scenario’, the animals were also adminis-
tered ten times that quantity (referred to as high dose).
Each gavage solution was prepared just prior to dosing by
weighing the largest reptile of each species and calculating the
maximal amount of anticoagulant to be consumed using the
appropriate equation described previously, in a volume of no
more than 0.5 mL propylene glycol (PG; Sigma-Aldrich, St. Louis,
MO, USA) for turtles or 1 mL for the other species (larger boas
received >1 mL volumes). The appropriate amount to dose the
entire group (plus overage) was weighed out and dissolved in
25 mL PG along with ≈7 mg of erioglaucine (a non-toxic blue
dye; Sigma-Aldrich), which was added to facilitate identification of
any emesis or regurgitation. Control animals received a gavage of
PG equivalent to the treatment volume administered to an animal
of that weight. Dosing solution concentrations, animal weight ranges
at first treatment, and dosage ranges for each species for both antico-
agulants at both concentrations are summarized in Table 3.
All animals were dosed via oral gavage on days 0 and 7 with the
appropriate anticoagulant in PG. To gavage, each reptile was held
firmly and its mouth gently opened and held open using an avian
oral speculum. Ball-tipped feeding needles were used to gavage
lizards and turtles, while red rubber catheter tubingwas used with
boas. After the first dosing, animals were observed at least four
times daily (every 2 h) as a general wellness check and for signs
Table 1. Summary of species and associated postures observed
Posture
Species Up on front legs Limbs near body Limbs extended Body curled up Body extended Pumping
Turtles x x x
Boa constrictors x x
Iguanas x x x x
Ameivas x x x x
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of anticoagulant intoxication (i.e. hemorrhaging) or distress.
Observations decreased to two times daily after that. A 7-day
observation period would likely allow sufficient time for symp-
toms to develop.
Since most of the animals used in this study were wild-caught, it
was likely that the stress of continued captivity could cause mor-
tality in some individuals. To distinguish stress-induced morality
from lethal intoxication, we determined prior to the start of the
study that only animals that either (i) displayed exterior (visible)
or interior hemorrhaging (on necropsy) with histological confir-
mation of coagulopathy or microangiopathy, or (ii) died after dos-
ing but prior to the end of the study and showing obvious
evidence of hemorrhaging would be counted as having experi-
enced lethal intoxication. Additional sources of external bleeding
could be loss of a claw or tooth/oral damage. The latter conditions
were occasionally seen in both ameivas and iquanas.
Twoweeks (day 14) after the first dosing, all animals were eutha-
nized, necropsied, and examined for gross signs of anticoagulant
intoxication. Both the thoracic and abdominal cavities were
closely examined for frank signs of bleeding and coagulopathy
or other abnormalities, which included anything related to coag-
ulation but also disease, health, and nutritional status. Tissue
and organ samples were also removed for subsequent
histopathology (see below). Livers and remaining carcasses were
frozen for subsequent high-pressure liquid chromatography
(HPLC) anticoagulant residues analysis. Turtle carcasses were
removed from their shells prior to freezing.
2.3 Histopathology
During necropsy, samples of heart muscle, skeletal muscle, liver,
spleen, kidney, alimentary tract, and mesentery were removed
and examined for bruising, frank blood, and any other observable
abnormalities. Tissues were then stored in 10% neutral buffered
formalin for subsequent histological examination by Northwest
Zoopath (Monroe, WA, USA).
2.4 Analytical determination of diphacinone and
brodifacoum in dosing solutions
To determine anticoagulant concentration in dosing solutions,
methanol was added to the solution and the sample was soni-
cated. The samples were then diluted into the linear range of
the instrument (reverse phase-high pressure liquid chromatogra-
phy, RP-HPLC) in a solution of 50% 5 mM tetrabutylammonium
perchlorate in pH 8.5 6 mM phosphate buffer/50% methanol
Table 2. Experimental animal numbers (n) and sex ratios by treatment
Species
Turtles Boa constrictors Iguanas Ameivas
Gavage Sex M F M F M F M F
Control (PG) 5 3 3 4 7 2 5 4
Low brodifacoum 5 5 3 5 6 3 5 4
High brodifacoum 2 2 3 5 8 2 5 4
Low diphacinone 1 6 4 4 6 3 6 4
High diphacinone 2 2 3 5 7 3 5 4
PG, propylene glycol.
Table 3. Dosing solution concentrations, first treatment animal weight ranges, and dosage ranges for each of four reptile species for both brodi-
facoum (B) and diphacinone (D) at two concentrations
Species Toxicant Level Gavage solution (μg mL−1) Weight range (kg) Dosage range (μg kg−1)
Wood turtles B 1× 160.4 0.253–0.902 91.4–119
B 10× 1605 0.315–0.915 887.7–1131
D 1× 301 0.194–0.965 166.5–234.4
D 10× 3070 0.322–0.778 1761–2151
Boa constrictors B 1× 160.4 0.480–5.190 59.8–102.7
B 10× 1605 0.500–4.290 625–1018
D 1× 308 0.470–3.730 125–198
D 10× 3070 0.370–4.440 1186–2085
Ameivas B 1× 20.3 0.036–0.142 134–183
B 10× 201.5 0.039–0.137 1339–1781
D 1× 41 0.044–0.141 239.2–311.8
D 10× 401.4 0.036–0.104 2508–3185
Iguanas B 1× 123 0.070–0.412 241.7–320.76
B 10× 1200 0.063–0.491 2293–3178
D 1× 214 0.055–0.409 421.3–581.2
D 10× 2090 0.056–0.459 4039–5635
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and filtered into vials for RP-HPLC analysis according to Pitt et al.6
with the following modifications: diphacinone and brodifacoum
concentrations were determined using an Agilent 1100 series
HPLC system and Luna C18, 3.0 μm, 50 × 3.0 mm column
(Phenomenex, Torrance, CA, USA). Diphacinone and brodifacoum
were detected via ultraviolet absorbance at 285 and 265 nm,
respectively.
2.5 Analytical determination of tissue residue levels
Residue levels of both brodifacoum and diphacinone were deter-
mined in liver and whole-body remainder (the entire carcasses
without the liver and tissues removed for histopathology, as well
as turtle carcasses with shells removed) by HPLC. Specifically,
livers were homogenized using liquid nitrogen with a mortar
and a pestle. The carcasses were skinned and processed through
a meat grinder followed by liquid nitrogen milling (SPEX Certi-
prep). Samples of 500 mg of each homogenate were weighed
into Teflon microwave tubes and then heated to 51.7 °C. Each
sample was analyzed twice: once for diphacinone residues and
again for brodifacoum residues.
Chlorophacinone and difenacoum were added to each sample
to serve as surrogate standards for diphacinone and brodifacoum,
respectively. Diphacinone and brodifacoum concentrations were
determined using an Agilent 1100 series HPLC system and Gemini
C18, 3.0 μm, 150 × 3.0 mm column (Phenomenex). Brodifacoum
and difenacoumwere detected using fluorescence with an excita-
tion wavelength of 273 nm and an emission wavelength of
390 nm.
2.6 Fecal occult blood tests
Fecal samples were tested for the presence of blood in an attempt
to determine if animals had clotting dysfunction without drawing
blood. Fecal samples were tested using both Hemoccult and
Hemoccult SENSA kits according to manufacturer's instructions
(Beckman Coulter, Brea, CA, USA).
2.7 Statistical methods
2.7.1 Anticoagulant residues
We calculatedmeans and standard errors of themeans for residue
levels of diphacinone and brodifacoum in livers and whole-body
remainders for each species and dose. Residue values that fell
below the method limit of detection (MLOD) were assigned a
value of half the MLOD.23
2.7.2 Behavioral/posture observations
The potential impacts of toxicant treatments on body weights,
behaviors, and postures noted throughout the study were
assessed using linear mixed effects regression models. While
many behaviors and postures were assessed, only variables with
a high enough frequency to provide adequate statistical power
were evaluated (Table 4). Each dependent variable (e.g. basking,
curled up) was modeled as a function of several fixed effects: tox-
icant treatment (control, brodificoum, or diphacinone), dose (0, 1,
or 10), week (week 1 after the first dose was administered or week
2 after the second dose was administered), and sex. Because
repeated measures were collected on individuals in different
weeks, individual animal ID was included as a random effect.
Interactions between treatment and dose (treatment*dose) and
treatment and week (treatment or dose) were tested and retained
if their inclusion reduced Akaike's Information Criterion.
3 RESULTS
3.1 Acute toxicity
Changes in weight were extremely variable across all groups, but
there were no consistent patterns of weight loss in any species for
any treatment group, suggesting that diet and animal care were
adequate and health status did not affect toxicity outcomes (data
not shown).
Administration of two gavage doses of diphacinone at the low
dose did not result in mortality in any of the animals tested. One
ameiva (female) in the high-dose diphacinone group died the
day following its second gavage; however, we observed no
hemorrhaging or coagulopathy on necropsy or in histopatholog-
ical examination of the tissues. In iguanas, evidence of non-lethal
internal and/or external hemorrhaging was observed in both low
and high diphacinone groups (Table 5).
Three ameivas (two females, onemale) and one iguana (male) in
the low dose brodifacoum group died during the test period, but
showed no obvious indications of anticoagulant intoxication. The
one iguana mortality in the low dose brodifacoum group showed
signs of anticoagulant intoxication with blood in the body cavity
noted at necropsy. One ameiva (male) died in the high dose bro-
difacoum group but did not show any signs of anticoagulation
intoxication. No post-dosing regurgitation was observed in any
animals. Additionally, several iguanas in both treatment groups
at both doses following treatment displayed markedly dark color-
ation, frequently considered a sign of stress.24 This change in col-
oration was not noted in any control animals. Similarly, several
treated ameivas were notably lethargic or unresponsive following
dosing, which again was not noted in controls.
3.2 Tissue residue levels
Residue levels of both brodifacoum and diphacinone were deter-
mined in liver and whole-body remainder (the entire carcasses
without the liver and tissues removed for histopathology). In boas,
ameivas, and iguanas brodifacoum levels were greater than
diphacinone levels for both low and high doses in the whole-body
remainder. Ameivas and iguanas had an almost 10-fold increase
in residue levels between low and high dose brodifacoum in the
whole-body remainder (0.12 and 1.16 μg g−1 for ameivas, respec-
tively; 0.18 and 1.57 μg g−1 for iguanas, respectively). Turtles had
a 5-fold increase in brodifacoum levels in the whole-body remain-
der between low and high doses (0.09 and 0.48 μg g−1, respec-
tively, Fig. 1).
Table 4. Behaviors and postures evaluated for each species
Species
Behavior
tested Posture tested
Ameiva Sleeping,
hiding,
basking
Curled up, on front legs, limbs near
body, limbs extended
Boa constrictors Inactive, hiding
Curled up
Iguana Hiding,
basking
Curled up, on front legs, limbs near
body
Turtle Inactive, hiding Alert, non-alert
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Contrary to the other species tested, turtles had greater diphaci-
none than brodifacoum levels in the whole-body remainder. For
both low and high doses, turtles had more than 2.5 times higher
diphacinone than brodifacoum residue levels in both high and
low doses. Turtles also had lower residue levels in the whole-body
remainder than all other species for high dose brodifacoum (Fig. 1).
Liver residue levels of brodifacoum and diphacinone were also
tested. All liver samples from all species had higher residue levels
than the whole-body remainder samples. Diphacinone levels in
the livers from amevias were only slightly greater than the
whole-body remainder residue levels (liver: low 0.127, high
0.096 μg g−1; whole-body remainder: low 0.015, high
0.028 μg g−1). Livers from ameivas and iguanas had the highest
brodifacoum residue concentrations (6.37 and 3.51 μg g−1,
respectively). Interestingly, turtles and boas had the highest liver
diphacinone concentrations (1.30 and 0.89 μg g−1, respec-
tively) (Fig. 2).
3.3 Histopathology
We observed no histopathological anomalies and no animal
exhibited any signs of treatment-related coagulopathy or
microangiopathy.
3.4 Fecal occult blood tests
There were no positive detections of occult blood in any fecal
sample from any of the species.
3.5 Behavioral/posture observations
3.5.1 Model results
Body weight did not vary over time in response to the different
treatment and dose groups for any of the four species. Similarly,
none of the behavioral variables tested showed significant differ-
ences between treatment groups. However, marginally significant
results for one of the posture variables for ameivas and one for
turtles were observed. Specifically, for ameivas, animals in the
10× brodificoum group exhibited the limbs near body posture
17% less frequently compared to controls (P < 0.04). Turtles in
the diphacinone group were significantly more likely to be non-
alert compared to turtles in the control and brodifacoum groups,
and this difference was greater for turtles in the 1× group (14%
more than other treatment groups, P < 0.02) than animals in the
10× diphacinone group (10%more than other treatment groups).
Because nearly 20 behavioral and postural variables were tested,
these relationships may be spurious (i.e. at a P < 0.05 threshold
Table 5. Summary of the effects of diphacinone and brodifacoum dosing on four species of reptiles
Turtles Boa constrictors Ameivas Iguanas
Dead/
dosed Hemorrhaging
Dead/
dosed Hemorrhaging
Dead/
dosed Hemorrhaging
Dead/
dosed Hemorrhaging
Control 0/8 0 0/7 0 0/9 0 0/9 0
Low diphacinone 0/8 0 0/8 0 0/10 0 0/9 1 E, 1 I
High diphacinone 0/4 0 0/8 0 1/9 0 0/10 2 E, 2 E & I
Low brodifacoum 0/8 0 0/8 0 3/9 0 1/9 1 E
High brodifacoum 0/4 0 0/8 0 1/9 0 0/10 1 E
I, internal hemorrhaging; E, external hemorrhaging.
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Figure 1. Residue levels found in whole-body remainder (carcasses without liver) from reptiles dosed with low or high levels of diphacinone or brodifa-
coum (mean ± SEM, μg g−1).
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we would expect to get one significant result across 20 compari-
sons just by chance) and should only be considered as potential
hypotheses for future study.
4 DISCUSSION
Neither diphacinone nor brodifacoum at either dose level caused
mortality in turtles or boas, indicating a lower risk probability asso-
ciated with exposure for either anticoagulant at the dosages
tested. This is especially true since the high doses of both roden-
ticides represented ten times the amount administered in the low
dose using generalized daily food intake estimates as an initial
approach to dosage selection.
Across three of the treatment groups (Table 5), a few ameivas
died during the study but showed no overt signs of internal or
external bleeding during necropsy or histological examination.
Several iguanas showed signs of anticoagulant intoxication, but
none of those animals died, with the only exception being an
iguana in the brodifacoum low dose group. This animal had coag-
ulated blood on the tip of its nose and in its mouth as well as
blood in the abdominal cavity. While anticoagulant-related hem-
orrhage is likely in this case, it seems problematic that a single ani-
mal in the low dose group would die when no iguanas in the high
dose group did.
As described previously, hemorrhaging and microangiopathy
were considered the most obvious signs of anticoagulant toxicity
in the reptiles used in this study. In a few previous studies in which
reptile carcasses were collected and necropsied following baiting
operations, hemorrhaging was observed in some or all of the
bodies.14,15 Interestingly, Merton15 noted that in ten Telfair's
skinks which had died following brodifacoum baiting opera-
tions on Round Island and subsequently analyzed, only one
showed indications of internal hemorrhaging, and suggested
that brodifacoum may have affected the lizards by unknown
non-hemorrhagic means, perhaps through interference with
thermoregulation.
Because of the paucity of literature addressing anticoagulant
toxicity in reptiles, all the possible symptoms of anticoagulant tox-
icity in reptiles may not be known. In the current study, since no
animals in the control group died, death in treated ameivas that
exhibited no hemorrhaging suggests the possibility of non-
hemorrhagic causes and indicates the need for further research
into anticoagulant toxicity in these species.
Additionally, there were no significant effects of anticoagulants
on the behaviors observed in this study. There were significant
treatment effects on postures in both turtles (limbs near body less
frequently) and ameivas (non-alert more likely), but the biological
significance of these observations is not obvious and needs to be
explored in future studies.
The majority of anticoagulant research has been done on mam-
mals. However, there are significant differences in the clotting
cascades of mammals and reptiles. Reptiles, and other poikilo-
therms, have noteworthy differences in physiology and specifi-
cally blood chemistry compared to their mammalian
counterparts. There are numerous reports stating that clotting
time in reptiles is greatly increased when compared to
mammals.25–31 Although reptiles have the extrinsic clotting path-
way, differences in many of the other factors have been
reported.32 Spectacled caimans are missing factors V, VII, IX, and
XI of the intrinsic (vitamin K dependent) pathway.33 Frost and col-
leagues30 reported that puff adders have reduced activity of pro-
thrombin, ⊍-antiplasmin, and kallikrein compared to humans.
These studies did not directly investigate the role that differences
in clotting mechanisms may have in affecting susceptibility to
anticoagulants; however, it seems likely that the physiological dif-
ferences would alter a reptile's response to diphacinone and bro-
difacoum when compared to mammals. More research needs to
be done to elucidate how these mechanistic changes in the clot-
ting cascade alter the risks to reptiles associated with anticoagu-
lant rodenticides.
Residue levels of diphacinone and brodifacoum in the reptiles in
this study were similar to those reported in previous studies; how-
ever, the doses given to these reptiles were very high when
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Figure 2. Residue levels found in liver tissue from reptiles dosed with low or high levels of diphacinone or brodifacoum (mean ± SEM, μg g−1).
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compared to other studies. Pitt et al.34 determined the diphaci-
none concentration in liver and muscle from feral swine fed
diphacinone rodenticide bait. The diphacinone residue level they
found, 1.733 μg g−1 in liver tissue, is similar to the turtle residue
levels at the diphacinone high dose in this study. It is greater than
the diphacinone residue levels found in all other species. The
average muscle residue level in the Pitt et al.34 study of
0.209 μg g−1 is less than the turtle whole-body remainder residue
levels found in this study, but comparable to the residue levels in
the other species dosed at the diphacinone high level. Slugs
(Limax maximus and Deroceras leave) and snails (Oxychilus spp.)
that were offered diphacinone bait for 7 days had whole-animal
residue levels in the range of residue levels found in all reptiles
in this study (L. maximus 0.61 μg g−1, D. leave 0.23 μg g−1, Oxychi-
lus spp 0.69 μg g−1).35
The brodifacoum residue levels found in this study were compa-
rable to those found in previous studies. In a study of voles
trapped in areas treated with brodifacoum bait, Merson et al.36
found residue levels of 2.07 and 4.07 μg g−1 depending on brodi-
facoum application rate. On days 2, 12, 34, and 210 following an
aerial baiting of Lady Alice Island, samples of cockroaches
(Blattidae), tree weta (Hemideina thoracica), cave weta (Gymno-
plectron spp.), and black beetles (Coleoptera) were collected and
analyzed for brodifacoum residues. No brodifacoumwas detected
in the tree weta, cockroaches, or black beetles, but 4.3 μg g−1 was
found in the cave weta on the baits.37 Brodifacoum residue levels
were greater than diphacinone levels in all species except turtles.
In the whole-body remainder in turtles, diphacinone residue
levels were 2.5 times greater than brodifacoum at both low and
high dose levels. In liver tissues, the residue levels of diphacinone
and brodifacoum were more similar. It is possible that these
unusual findings are a result of different metabolic pathways in
turtles.
The finding that, in general, these reptiles had residue levels
comparable to mammal residue levels even though the reptiles
received larger quantities of diphacinone and brodifacoum than
most mammal studies warrants further consideration. These dif-
ferences in residue levels may be a result of differences in meta-
bolic pathways. In mammals, the cytochrome P-450 pathway is
responsible for the metabolism of most anticoagulants. Although,
in general, reptiles possess most of the same phase I metabolic
enzymes as mammals, the amount cytochrome P-450 in reptiles
is significantly lower than that found in mammals.38–40 Also, when
compared to mammals, reptiles have been shown to have differ-
ent cytochrome P-450 activity levels and the response of these
enzymes to the presence of inducing compounds.38,41 Andersson
and Nilsson39 found significant differences in cytochrome P-450
metabolism in their study of hag fish (Myxine glutinosa), dogfish
(Scualus acanthias), perch (Perca fluvtatilis), and caiman (Caiman
sclerops). It is possible that other phase I metabolic pathways are
responsible for anticoagulant metabolism in reptiles, which may
explain the variations in residue levels.
5 CONCLUSION
Comparedwith the lizards used in this study, the wood turtles and
boas appear to be relatively insensitive to diphacinone and brodi-
facoum. No animals from either of these species showed overt
hemorrhaging or any other signs of intoxication in response to
anticoagulants. In contrast, internal and external hemorrhaging
was found in iguanas dosed with low and high levels of
diphacinone and brodifacoum, although only one iguana died
due to likely intoxication.
In ameivas, the fact that several treated (but not control) ani-
mals died but showed no signs of any hemorrhaging or microan-
giopathy suggests that anticoagulants may exert effects other
than inhibition of coagulation. Further research into anticoagu-
lant toxicology in this species is clearly needed.
Brodifacoum residue levels in liver and whole-body remainder
were higher in boas, ameivas, and iguanas while diphacinone
levels were higher than brodifacoum levels in turtles. Hopefully,
these results will be useful in the determination of non-target risks
to these and related species associated with anticoagulant use in
future rodent control operations.
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